206 related articles for article (PubMed ID: 18571966)
21. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
22. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.
Levin VA; Rodriguez LA; Edwards MS; Wara W; Liu HC; Fulton D; Davis RL; Wilson CB; Silver P
J Neurosurg; 1988 Mar; 68(3):383-7. PubMed ID: 3343610
[TBL] [Abstract][Full Text] [Related]
23. Medulloblastoma in two successive pregnancies.
Razak AR; Nasser Q; Morris P; Alcutt D; Grogan L
J Neurooncol; 2005 May; 73(1):89-90. PubMed ID: 15933823
[TBL] [Abstract][Full Text] [Related]
24. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
25. Medulloblastoma.
Hirsch JF; Hoppe-Hirsch E
Adv Tech Stand Neurosurg; 1993; 20():165-96. PubMed ID: 8397534
[No Abstract] [Full Text] [Related]
26. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.
Sure U; Bertalanffy H; Isenmann S; Brandner S; Berghorn WJ; Seeger W; Aguzzi A
Acta Neurochir (Wien); 1995; 136(3-4):117-26. PubMed ID: 8748840
[TBL] [Abstract][Full Text] [Related]
27. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic medulloblastoma in a child with Duchenne muscular dystrophy.
van den Akker M; Northcott P; Taylor MD; Halliday W; Bartels U; Bouffet E
J Neurosurg Pediatr; 2012 Jul; 10(1):21-4. PubMed ID: 22702330
[TBL] [Abstract][Full Text] [Related]
29. Medulloblastoma with extensive nodularity undergoing post-therapeutic maturation to a gangliocytoma: a case report and literature review.
Chelliah D; Mensah Sarfo-Poku C; Stea BD; Gardetto J; Zumwalt J
Pediatr Neurosurg; 2010; 46(5):381-4. PubMed ID: 21389751
[TBL] [Abstract][Full Text] [Related]
30. Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy.
Sterba J; Pavelka Z; Andre N; Ventruba J; Skotakova J; Bajciova V; Bronisova D; Dubska L; Valik D
Pediatr Blood Cancer; 2010 Apr; 54(4):616-7. PubMed ID: 19967772
[TBL] [Abstract][Full Text] [Related]
31. Late postirradiation occlusive vasculopathy in childhood medulloblastoma. Report of two cases.
Grenier Y; Tomita T; Marymont MH; Byrd S; Burrowes DM
J Neurosurg; 1998 Sep; 89(3):460-4. PubMed ID: 9724122
[TBL] [Abstract][Full Text] [Related]
32. Is there a danger in delaying radiotherapy in childhood medulloblastoma?
Attard-Montalto S; Plowman N; Breatnach F; Saha V; Eden OB
Br J Radiol; 1993 Sep; 66(789):807-13. PubMed ID: 8220953
[TBL] [Abstract][Full Text] [Related]
33. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
Grill J; Sainte-Rose C; Jouvet A; Gentet JC; Lejars O; Frappaz D; Doz F; Rialland X; Pichon F; Bertozzi AI; Chastagner P; Couanet D; Habrand JL; Raquin MA; Le Deley MC; Kalifa C;
Lancet Oncol; 2005 Aug; 6(8):573-80. PubMed ID: 16054568
[TBL] [Abstract][Full Text] [Related]
34. Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.
Sabel M; Fleischhack G; Tippelt S; Gustafsson G; Doz F; Kortmann R; Massimino M; Navajas A; von Hoff K; Rutkowski S; Warmuth-Metz M; Clifford SC; Pietsch T; Pizer B; Lannering B;
J Neurooncol; 2016 Sep; 129(3):515-524. PubMed ID: 27423645
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
36. [Results of radiation therapy for medulloblastoma].
Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
[TBL] [Abstract][Full Text] [Related]
37. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
[TBL] [Abstract][Full Text] [Related]
38. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
39. Treatment of medulloblastoma in adults.
Hartsell WF; Montag AG; Lydon J; Galinsky DL; Sarin P
Am J Clin Oncol; 1992 Jun; 15(3):207-11. PubMed ID: 1590272
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastomas.
Castro-Vita H; Salazar OM; Scarantino C; Rubin P; De Cova M
Rev Interam Radiol; 1980 Jul; 5(3):77-82. PubMed ID: 7455518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
